PGR and breast cancer: Based on the expression levels of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 (HER2) protein, BC is divided into three categories: luminal, HER2-positive (HER2+), and triple-negative BC (TNBC: ER−/PR−HER2−) subtypes.